323 related articles for article (PubMed ID: 31894265)
21. Global metabolomic and lipidomic analysis reveals the potential mechanisms of hemolysis effect of Ophiopogonin D and Ophiopogonin D' in vivo.
Xu HH; Jiang ZH; Huang CS; Sun YT; Xu LL; Tang XL; Tan HL; Ma ZC; Gao Y
Chin Med; 2021 Jan; 16(1):3. PubMed ID: 33407692
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.
Qiu X; Klausen C; Cheng JC; Leung PC
Cell Death Dis; 2015 Aug; 6(8):e1864. PubMed ID: 26313915
[TBL] [Abstract][Full Text] [Related]
23. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the Fas/FasL signaling pathway in renal tubular cells.
Zhu Y; Cui H; Lv J; Li G; Li X; Ye F; Zhong L
PLoS One; 2020; 15(3):e0228385. PubMed ID: 32134954
[TBL] [Abstract][Full Text] [Related]
25. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
26. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
[TBL] [Abstract][Full Text] [Related]
27. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.
Jouan-Lanhouet S; Arshad MI; Piquet-Pellorce C; Martin-Chouly C; Le Moigne-Muller G; Van Herreweghe F; Takahashi N; Sergent O; Lagadic-Gossmann D; Vandenabeele P; Samson M; Dimanche-Boitrel MT
Cell Death Differ; 2012 Dec; 19(12):2003-14. PubMed ID: 22814620
[TBL] [Abstract][Full Text] [Related]
28. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.
Orozco S; Yatim N; Werner MR; Tran H; Gunja SY; Tait SW; Albert ML; Green DR; Oberst A
Cell Death Differ; 2014 Oct; 21(10):1511-21. PubMed ID: 24902904
[TBL] [Abstract][Full Text] [Related]
29. Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
Zhuang C; Chen F
J Med Chem; 2020 Feb; 63(4):1490-1510. PubMed ID: 31622096
[TBL] [Abstract][Full Text] [Related]
30. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
31. Key roles of necroptotic factors in promoting tumor growth.
Liu X; Zhou M; Mei L; Ruan J; Hu Q; Peng J; Su H; Liao H; Liu S; Liu W; Wang H; Huang Q; Li F; Li CY
Oncotarget; 2016 Apr; 7(16):22219-33. PubMed ID: 26959742
[TBL] [Abstract][Full Text] [Related]
32. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
[TBL] [Abstract][Full Text] [Related]
33. Astaxanthin induces NADPH oxidase activation and receptor‑interacting protein kinase 1‑mediated necroptosis in gastric cancer AGS cells.
Kim S; Lee H; Lim JW; Kim H
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34608499
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
35. Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis.
Chen L; Liu L; Chen Y; Liu M; Xiong Y; Zhang H; Huang S; Xia C
Xenobiotica; 2019 Oct; 49(10):1221-1228. PubMed ID: 29944058
[No Abstract] [Full Text] [Related]
36. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
Front Immunol; 2018; 9():1818. PubMed ID: 30154785
[TBL] [Abstract][Full Text] [Related]
37. Detecting Necroptosis in Virus-Infected Cells.
Cotsmire SM; Szczerba M; Jacobs BL
Methods Mol Biol; 2021; 2225():199-216. PubMed ID: 33108664
[TBL] [Abstract][Full Text] [Related]
38. The multitargeted kinase inhibitor KW-2449 ameliorates cisplatin-induced nephrotoxicity by targeting RIPK1-mediated necroptosis.
Rui C; Shi SN; Ren W; Qin X; Zhuang C; Chen X; Chen G; Yu J; Wang HY; Cai Z
Biochem Pharmacol; 2021 Jun; 188():114542. PubMed ID: 33819469
[TBL] [Abstract][Full Text] [Related]
39. Scaffold hopping derived novel benzoxazepinone RIPK1 inhibitors as anti-necroptosis agents.
Tang J; Wu Y; Zhao W; Qu Z; Yu J; Wang Z; Shi Y
Bioorg Med Chem; 2023 Aug; 91():117385. PubMed ID: 37364415
[TBL] [Abstract][Full Text] [Related]
40. Acetylshikonin induces necroptosis via the RIPK1/RIPK3-dependent pathway in lung cancer.
Lin SS; Chang TM; Wei AI; Lee CW; Lin ZC; Chiang YC; Chi MC; Liu JF
Aging (Albany NY); 2023 Dec; 15(24):14900-14914. PubMed ID: 38126996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
